Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01941927
Title Trametinib With GSK2141795 in BRAF Wild-type Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Adil Daud
Indications

melanoma

Therapies

Trametinib + Uprosertib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California, San Francisco San Francisco California 94115 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field